Matches in SemOpenAlex for { <https://semopenalex.org/work/W2206325824> ?p ?o ?g. }
- W2206325824 endingPage "476" @default.
- W2206325824 startingPage "471" @default.
- W2206325824 abstract "Clofarabine, a purine nucleoside analogue and inhibitor of Ribonucleotide Reductase (RR), is used for treatment of leukemia. Clofarabine-induced defect in DNA replication, induces p53 and subsequently P53R2 genes as subunit of RR. clofarabine deregulated P53R2 gene expression leading to the elevated levels of P53R2 which impose resistance to DNA damaging drugs. In this study the apoptotic and cytotoxic effects of clofarabine has been investigated on breast cancer cell line.Cofarabine cytotoxicity on T47D cells has been studied by MTT assay. T47D cells were exposed to the different concentrations of clofarabine for 24, 48 and 72 hours intervals. Relative expression of P53R2 gene has been studied using real-time PCR. Moreover, after treating with clofarabine the apoptotic and necrotic cells were detected using Annexin V and propodium iodide (PI) reagents by flowcytometry technique.MTT assay results showed that the clofarabine IC50 on T47D cell line were 3 and 2.5µM after 48 and 72 h exposure, respectively. Clofarabine did not show any significant cytotoxic effect after 24 h exposure. The analysis of qRT-PCR showed a significant increase in P53R2 gene expression in treated cells with both 2.5 and 3 μM doses and also, the results of flowcytometry revealed 26.91 and 74.46 percent apoptosis induction in 48 and 72h treatments respectively in comparison to the control groups.Our results showed that apoptotic and cytotoxic effects of clofarabine on T47D cell line were in time and dose dependent manner; therefore it could be considered a new candidate in breast cancer therapy." @default.
- W2206325824 created "2016-06-24" @default.
- W2206325824 creator A5000946437 @default.
- W2206325824 creator A5008839777 @default.
- W2206325824 creator A5009595521 @default.
- W2206325824 creator A5015393806 @default.
- W2206325824 creator A5030873957 @default.
- W2206325824 creator A5031465304 @default.
- W2206325824 creator A5039874296 @default.
- W2206325824 creator A5054918045 @default.
- W2206325824 creator A5059835414 @default.
- W2206325824 creator A5082812386 @default.
- W2206325824 date "2015-11-30" @default.
- W2206325824 modified "2023-10-16" @default.
- W2206325824 title "Clofarabine Has Apoptotic Effect on T47D Breast Cancer Cell Line via P53R2 Gene Expression" @default.
- W2206325824 cites W1963779075 @default.
- W2206325824 cites W1975131304 @default.
- W2206325824 cites W1997112174 @default.
- W2206325824 cites W1999408218 @default.
- W2206325824 cites W2005278252 @default.
- W2206325824 cites W2012914676 @default.
- W2206325824 cites W2021817174 @default.
- W2206325824 cites W2025876695 @default.
- W2206325824 cites W2026981180 @default.
- W2206325824 cites W2037469012 @default.
- W2206325824 cites W2042006572 @default.
- W2206325824 cites W2049525659 @default.
- W2206325824 cites W2062811597 @default.
- W2206325824 cites W2096855371 @default.
- W2206325824 cites W2103961908 @default.
- W2206325824 cites W2104895073 @default.
- W2206325824 cites W2116171965 @default.
- W2206325824 cites W2143391022 @default.
- W2206325824 cites W2144169031 @default.
- W2206325824 cites W2149464340 @default.
- W2206325824 cites W2150145618 @default.
- W2206325824 cites W2153735696 @default.
- W2206325824 cites W2160881482 @default.
- W2206325824 cites W2169612030 @default.
- W2206325824 cites W4245282361 @default.
- W2206325824 doi "https://doi.org/10.15171/apb.2015.064" @default.
- W2206325824 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4729341" @default.
- W2206325824 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26819918" @default.
- W2206325824 hasPublicationYear "2015" @default.
- W2206325824 type Work @default.
- W2206325824 sameAs 2206325824 @default.
- W2206325824 citedByCount "4" @default.
- W2206325824 countsByYear W22063258242016 @default.
- W2206325824 countsByYear W22063258242017 @default.
- W2206325824 crossrefType "journal-article" @default.
- W2206325824 hasAuthorship W2206325824A5000946437 @default.
- W2206325824 hasAuthorship W2206325824A5008839777 @default.
- W2206325824 hasAuthorship W2206325824A5009595521 @default.
- W2206325824 hasAuthorship W2206325824A5015393806 @default.
- W2206325824 hasAuthorship W2206325824A5030873957 @default.
- W2206325824 hasAuthorship W2206325824A5031465304 @default.
- W2206325824 hasAuthorship W2206325824A5039874296 @default.
- W2206325824 hasAuthorship W2206325824A5054918045 @default.
- W2206325824 hasAuthorship W2206325824A5059835414 @default.
- W2206325824 hasAuthorship W2206325824A5082812386 @default.
- W2206325824 hasBestOaLocation W22063258241 @default.
- W2206325824 hasConcept C104292427 @default.
- W2206325824 hasConcept C104317684 @default.
- W2206325824 hasConcept C109316439 @default.
- W2206325824 hasConcept C153911025 @default.
- W2206325824 hasConcept C154317977 @default.
- W2206325824 hasConcept C185592680 @default.
- W2206325824 hasConcept C190283241 @default.
- W2206325824 hasConcept C202751555 @default.
- W2206325824 hasConcept C2776543447 @default.
- W2206325824 hasConcept C2777198975 @default.
- W2206325824 hasConcept C2777333352 @default.
- W2206325824 hasConcept C2778041864 @default.
- W2206325824 hasConcept C2778729363 @default.
- W2206325824 hasConcept C2780783641 @default.
- W2206325824 hasConcept C4710235 @default.
- W2206325824 hasConcept C502942594 @default.
- W2206325824 hasConcept C53227056 @default.
- W2206325824 hasConcept C55493867 @default.
- W2206325824 hasConcept C71924100 @default.
- W2206325824 hasConcept C86803240 @default.
- W2206325824 hasConceptScore W2206325824C104292427 @default.
- W2206325824 hasConceptScore W2206325824C104317684 @default.
- W2206325824 hasConceptScore W2206325824C109316439 @default.
- W2206325824 hasConceptScore W2206325824C153911025 @default.
- W2206325824 hasConceptScore W2206325824C154317977 @default.
- W2206325824 hasConceptScore W2206325824C185592680 @default.
- W2206325824 hasConceptScore W2206325824C190283241 @default.
- W2206325824 hasConceptScore W2206325824C202751555 @default.
- W2206325824 hasConceptScore W2206325824C2776543447 @default.
- W2206325824 hasConceptScore W2206325824C2777198975 @default.
- W2206325824 hasConceptScore W2206325824C2777333352 @default.
- W2206325824 hasConceptScore W2206325824C2778041864 @default.
- W2206325824 hasConceptScore W2206325824C2778729363 @default.
- W2206325824 hasConceptScore W2206325824C2780783641 @default.
- W2206325824 hasConceptScore W2206325824C4710235 @default.
- W2206325824 hasConceptScore W2206325824C502942594 @default.
- W2206325824 hasConceptScore W2206325824C53227056 @default.